- Home
- BLFS vs ASTH Comparison
BLFS vs ASTH Comparison
Compare BLFS & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- ASTH
- Stock Information
- Founded
- BLFS 1987
- ASTH 1994
- Country
- BLFS United States
- ASTH United States
- Employees
- BLFS N/A
- ASTH N/A
- Industry
- BLFS Medical/Dental Instruments
- ASTH Professional Services
- Sector
- BLFS Health Care
- ASTH Consumer Discretionary
- Exchange
- BLFS Nasdaq
- ASTH Nasdaq
- Market Cap
- BLFS 1.2B
- ASTH 1.4B
- IPO Year
- BLFS 1989
- ASTH N/A
- Fundamental
- Price
- BLFS $26.46
- ASTH $29.70
- Analyst Decision
- BLFS Strong Buy
- ASTH Strong Buy
- Analyst Count
- BLFS 7
- ASTH 8
- Target Price
- BLFS $30.86
- ASTH $53.29
- AVG Volume (30 Days)
- BLFS 606.5K
- ASTH 463.9K
- Earning Date
- BLFS 08-07-2025
- ASTH 08-07-2025
- Dividend Yield
- BLFS N/A
- ASTH N/A
- EPS Growth
- BLFS N/A
- ASTH N/A
- EPS
- BLFS N/A
- ASTH 0.52
- Revenue
- BLFS $93,468,000.00
- ASTH $2,419,115,000.00
- Revenue This Year
- BLFS $26.07
- ASTH $60.77
- Revenue Next Year
- BLFS $16.86
- ASTH $26.90
- P/E Ratio
- BLFS N/A
- ASTH $56.81
- Revenue Growth
- BLFS 68.16
- ASTH 51.97
- 52 Week Low
- BLFS $19.10
- ASTH $21.20
- 52 Week High
- BLFS $29.55
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- BLFS 66.89
- ASTH 54.98
- Support Level
- BLFS $24.64
- ASTH $29.95
- Resistance Level
- BLFS $26.29
- ASTH $32.16
- Average True Range (ATR)
- BLFS 0.80
- ASTH 1.07
- MACD
- BLFS 0.03
- ASTH -0.14
- Stochastic Oscillator
- BLFS 98.13
- ASTH 28.90
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.